Copanlisib Plus Venetoclax in R/R DLBCL

NCT04572763 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B Cell Lymphoma
Relapsed Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma

Interventions

DRUG: Copanlisib
DRUG: Venetoclax

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]